Feed Insights Top Reports Pricing

⌘K

16:07:14·1370d

SECFilingvia Quantisnow

SEC Form DEF 14A filed by Vectrus Inc.

ByQuantisnow·Wall Street's wire, on your screen.

VEC· Vectrus Inc.

Plus alert sent

Quantisnow Plus members were alerted at 16:07:15 ET - 1.8s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment VEC files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VEC (Vectrus Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Vectrus Inc. filed SEC Form 8-K: Shareholder Director Nominations, Other Events
SEC Form 4: Boyington John Edward Jr. converted options into 517,918 units of V2X and covered exercise/tax liability with 200,394 units of V2X
SEC Form 4: Mendoza Richard covered exercise/tax liability with 5,540 units of V2X and converted options into 18,207 units of V2X
SEC Form 4: Beard William Wayne converted options into 29,315 units of V2X and covered exercise/tax liability with 10,034 units of V2X
SEC Form 4: Noon William Boyd bought $21,140 worth of V2X (500 units at $42.28), increasing direct ownership by 10% to 5,740 units

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022